Morphometric evidence for impairment of renal autoregulation in advanced essential hypertension  by Hill, G.S. et al.
Morphometric evidence for impairment of renal
autoregulation in advanced essential hypertension
GS Hill1, D Heudes1, C Jacquot1, E´ Gauthier1 and J Barie´ty1
1Hoˆpital Europe´en Georges Pompidou and INSERM Unite´ 652, Paris, France
A morphometric study was performed on 22 renal biopsies
from hypertensive patients with proteinuria and/or azotemia,
with no evidence of other renal disease. These results were
compared with our earlier study of normotensive aging
kidneys. Afferent arterioles in hypertensive kidneys showed a
significant increase in lumen diameter (15.774.9 vs
13.474.7 lm, P¼ 0.0007) and wall area (12347769 vs
9987445 lm2, P¼ 0.037), due primarily to shift in the
distribution of arteriolar types, from predominantly normal
toward predominantly hyaline arterioles in hypertension.
Glomeruli were divided into four basic types: normal,
hypertrophic, focal segmental glomerulosclerosis (FSGS)
type, and sclerosing. Overall, glomeruli in hypertensive
kidneys were much larger than in normotensive aging
kidneys, for example, total capillary area (16 247710 681 vs
11 62475702 lm2, Po0.00001). This increase was due
primarily to an increase in size of each type, for example, for
hypertrophic glomeruli: total capillary area (22 205710 426
vs 15 34974577 lm2, P¼ 0.0038). There was an excellent
correlation between arteriolar lumen diameter and mean
glomerular capillary area for hypertrophic/FSGS-type
glomeruli (r¼ 0.4778, P¼ 0.0013), such that as arteriolar
diameter increases the mean glomerular capillary area
increases, consistent with loss of autoregulation. The
morphologic correlates of loss of autoregulation, with
afferent arteriolar dilatation and increase in glomerular
capillary size, glomerular hypertrophy, and subsequent FSGS,
are present on a focal basis in aging kidneys and, much more
extensively, although still focally, in hypertensive kidneys.
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Loss of autoregulation of renal blood flow at the afferent
arteriolar level leads to the transmission of elevated pressures
to the now-unprotected glomerulus, with ensuing hyper-
filtration and hypertrophy and eventual focal segmental
glomerulosclerosis (FSGS).1 Although loss of renal auto-
regulation has been established for a number of years as an
important mechanism in the progression of experimental
hypertension and diabetes,1–4 only in recent years is it coming
to be appreciated that loss of autoregulation may play a role
in renal disease in man as well.5–7 Loss of autoregulation is, of
course, a functional determination, but, experimentally, the
morphologic correlates of this loss are afferent arteriolar
dilatation8,9 and glomerular hypertrophy with progression to
FSGS.1,10,11
In earlier studies,12 we found that lesions consistent with
loss of autoregulation, in the form of dilated afferent
arterioles serving hypertrophic or FSGS-type glomeruli, were
present on a focal basis in the normotensive aging kidney.
This study extends the observations in normotensive aging
kidneys to hypertensive kidneys to evaluate the differences
supervening with hypertension. We studied renal biopsies
from patients with essential hypertension biopsied for
proteinuria and/or elevated serum creatinine. This group
admittedly represents the far end of the spectrum of essential
hypertension, probably at most 3–5% of cases. However, it
should presumably show the lesions in their most florid
form, as two prior series have indeed demonstrated.13,14
It was found that there is a shift in the distribution of
glomeruli from a predominance of normal glomeruli in aging
kidneys to a majority of hypertrophic and FSGS-type
glomeruli in hypertensive kidneys, with a corresponding
increase in the overall glomerular size. There is a parallel shift
among arterioles, from predominantly normal arterioles
without hyaline deposits to predominantly hyaline arterioles,
with corresponding increases in overall lumen size. Thus, the
morphologic correlates of loss of autoregulation are greatly
increased in the hypertensive kidney.
RESULTS
Preliminary analysis
After initial analysis of the other glomerular types, 10
glomeruli initially regarded as indeterminate were reclassified
as described previously,12 using the morphologic parameters
established for the other groups on preliminary analysis.
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Three of the 10 were reclassified as normal, six as
hypertrophic, and one as sclerosing.
Arterioles
Compared to normal aging kidneys, the arterioles in
hypertensive kidneys have larger lumens and luminal
diameters, an increase in the arteriolar smooth muscle and
ECM, and a corresponding increase in outer circumference
(Table 1). However, there are no significant differences
between hypertensive and normotensive kidneys for a given
arteriolar type. The overall differences in size come primarily
from a difference in the distribution of types, with a shift
from predominantly normal arterioles to predominantly
hyaline arteriolosclerosis (w2¼ 11.97, P¼ 0.0025) (Table 1).
Dividing arterioles by the type of glomeruli they serve
(Table 2), it is seen that arterioles to hypertrophic/FSGS-type
glomeruli are markedly larger not only in terms of overall
lumen area and diameter but also in the area and thickness of
the muscularis (Table 2), both in hypertensive and normo-
tensive kidneys. This increase seems likely to represent
muscle hypertrophy in response to the increased tension
implied by the increased luminal radius (Laplace’s law). To
study this issue, we compared arterioles to normal glomeruli
with those to hypertrophic/FSGS-type glomeruli within the
same biopsy. (This was done to minimize problems of
differences of pressure between cases, assuming that the
pressures in all of the arterioles in a given biopsy would be
similar, a reasonable first approximation.) As seen in Table 3,
there is a parallel increase in the mean ratios between
hypertensive and normotensive kidneys, greater in the
hypertensive kidneys, as would be expected from the greater
pressures. However, the data suggest that the hypertrophy in
hypertensive patients may be functionally inefficacious, since
in normotensives the ratio of increase in lumen diameter
(1.5270.43) is virtually identical to that in wall area
(1.5270.73), whereas in hypertensives the relative increase
in wall area (2.5171.04) far exceeds that of the increase in
diameter (1.3570.29).
In normotensive aging kidneys, roughly 90% of hyper-
trophic and FSGS-type glomeruli were served by arterioles
Table 1 | Comparison of arterioles between aging and
hypertensive kidneys (measurements in lm or lm2 as
appropriate)
Parameter Aging Hypertensive P
Arteriolar parameters
No. of observations 126 68
Lumen
Area 2957226 3807298 0.01
Width 13.474.7 15.774.9 0.0007
Wall
Area S/M+ECM 9987445 11687733 0.02
Area deposits 47.4776.3 65.4769.4 0.05
Area total 10467499 12347769 0.02
Thickness S/M 15.975.3 17.075.3 0.08
Outer circumference 2227101 243793 0.08
Wall/lumen ratio 5.1875.11 4.0672.24 0.04
Arteriolar types
No deposits 70 (55.5%) 17 (25.0%) w2=16.67
Hyaline deposits 56 (45.5%) 51 (75.0%) Po0.0001
ECM=extracellular matrix; S/M=smooth muscle.
Table 2 | Glomerular and arteriolar parameters by glomerular type (measurements in lm or lm2 as appropriate)
Normal eight
observations
Hypertrophic 32
observations P vs Nl
FSGS-type 16
observations P vs Nl
Sclerosing 12
observations P vs Nl
Percentage of glomeruli
Hypertension (68 observations) 8 (11.7%) 32 (47.1%) 16 (23.5%) 12 (17.6%) w2=33.34
Normotensive aging (126
observations)
82 (65.1%) 22 (17.5%) 10 (7.9%) 12 (9.5%)
Glomerular parameters
Total tuft area 18 10375462 30 040712 206 0.007 24 182711 005 NS 11 20176856 0.03
Total capillaries area 11 02573470 20 53878801 0.003 15 62378993 NS 592674560 0.01
Hilar caps (total area) 557165 79771124 0.06 95571291 0.05 2577573 NS
Other caps (mean area) 65720 116739 0.0007 100753 0.07 53721 NS
Arteriolar parameters
Lumen
Area 139738 4847330 0.006 3857252 0.01 2167167 NS
Diameter 11.671.7 17.574.9 0.002 16.175.1 0.02 12.272.3 NS
Wall
Area – Muscle+ECM 5737218 14267854 0.008 11267545 0.01 8327421 NS
Area of deposits 11721 78766 0.001 89788 0.02 43710 0.002
Area – total 5847203 15037887 0.001 12157610 0.01 8667419 NS
Thickness wall 13.474.3 18.474.3 0.001 16.574.5 0.02 NS
Arteriolar types
No deposits 5 (62.5%) 3 (9.4%) 4 (25.0%) 4 (33.3%)
Hyaline deposits 3 (37.5%) 29 (90.6%) 12 (75.0%) 8 (66.7%)
ECM=extracellular matrix; Nl=Normal; NS=nonsignificant.
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with hyaline deposits, so much so that it was suggested that
hyaline deposits were a rough marker for loss of autoregula-
tion. This is true to a lesser extent in hypertensive kidneys,
though some normal glomeruli have hyaline arterioles and a
greater percentage of hypertrophic/FSGS glomeruli are served
by arterioles that, at least in the plane of section, show no
hyaline deposits (Table 2).
Glomeruli
Compared to normal kidneys, hypertensive kidneys show a
shift away from normal glomeruli toward hypertrophic and
FSGS-type glomeruli (Table 2), and the glomerular para-
meters, considered overall, are augmented (Table 4).
Both aging and hypertensive kidneys glomeruli show a
characteristic pattern of increase in size, total and mean
capillary areas, with associated increases in arteriolar lumen
and media size, with progression to hypertrophic glomeruli,
and diminution in these parameters as FSGS changes
supervene, although values remain higher than those in
normal glomeruli. As expected, sclerosing glomeruli show
diminution in all these parameters below normal levels. All of
these responses are exaggerated in the hypertensive kidney
(Figure 1).
Comparison of glomerular types between aging and
hypertensive kidneys
The glomeruli of each type are generally larger in hyperten-
sive than in aging kidneys (Figure 1). Specific comments
regarding each type follow:
Normal glomeruli. Normal glomeruli in hypertensive
kidneys differ significantly from their counterparts in aging
kidneys only in the mean area of individual capillaries
(66.8720.8 vs 87.2725.6 mm2, P¼ 0.03). However, their
feeding arterioles have smaller wall areas (5847203 vs
10127486 mm2, P¼ 0.016) and likely smaller luminal areas
(139738 vs 2377159 mm2, P¼ 0.09).
Hypertrophic glomeruli. These glomeruli are significantly
larger in every measured parameter than hypertrophic
glomeruli in aging kidneys (the latter are already significantly
larger than their normal counterparts). For example, the total
area of glomerular capillaries is 1.31 times that in aging
kidneys (20 22178687 vs 15 34974577mm2, P¼ 0.02).
FSGS-type glomeruli
These glomeruli are larger in the hypertensive kidneys than in
aging kidneys in all parameters, but differences are modest
and do not reach significance. Their arterioles, although
much larger than normal arterioles, do not differ between
aging and hypertensive kidneys.
Sclerosing glomeruli. Sclerosing glomeruli could be bro-
ken into two separate types of lesions, those of ischemic
Table 4 | Comparison of glomeruli between aging and
hypertensive kidneys
Parameter Aging Hypertensive P
Glomerular parameters
No. of observations 126 68
Total tuft 16 67377758 23 289712 033 o0.00001
Extracellular matrix 503172608 797773797 o0.00001
Total capillary surface 11 63475702 15 26879300 0.0009
Hilar capillaries (total) 9717717 168471121 o0.00001
Other capillaries
(mean)
89.1731.0 93.9745.9 NS
Periglomerular region %
extracellular matrix
57716 69715 o0.00001
Glomerular types
Normal 82 (65.1%) 8 (11.7%)
Hypertrophic 21 (16.7%) 32 (47.1%) w2=33.65
FSGS-type 10 (7.9%) 16 (23.5%) Po0.000001
Ischemic/sclerosing 13 (10.3%) 12a (17.3%)
FSGS=focal segmental glomerulosclerosis.
aConsists of five (7.3%) ischemic and seven (10.3%) FSGS-type sclerosing glomeruli.
Table 3 | Mean ratios between values for arterioles to hypertrophic/FSGS-type glomeruli compared to those to normal
glomeruli within individual biopsies
Ratio lumen area Ratio lumen diameter Ratio wall thickness Ratio wall ara Ratio outer diameter
Hypertensive (13 observations) 2.5871.34 1.3570.29 1.5770.51 2.5171.04 1.4670.25
Normotensive aging (24 observations) 1.3871.16 1.5270.43 1.047029 1.5270.73 1.1570.25
P 0.0074 NS 0.003 0.0018 NS
FSGS=focal segmental glomerulosclerosis; NS=nonsignificant.
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Figure 1 | Glomerular and arteriolar parameters in aging and
hypertensive kidneys. Values for both aging and hypertensive
kidneys are standardized to a value of 1.0 for normal glomeruli and
their associated arterioles in aging kidneys. Both aging and
hypertensive kidneys show an increase in all parameters, both
glomerular and arteriolar, in hypertrophic glomeruli, followed by a
decrease in FSGS type and sclerosing glomeruli. These differences,
however, are much more marked in hypertensive kidneys. *Value
significantly different from that for normal glomeruli in aging kidneys.
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origin (seven observations) and those representing progres-
sive sclerosis of FSGS-type glomeruli (five observations). The
ischemic glomeruli differed from ischemic glomeruli in
normal kidneys only in increased extracellular matrix
(385471322 vs 25617869 mm2, P¼ 0.001). The FSGS-type
sclerosing glomeruli were larger than ischemic glomeruli in
every parameter in either normotensive or hypertensive
kidneys, for example, total capillary area (817775731 vs
389972891mm2, P¼ 0.001), consonant with hypertrophy
prior to sclerosis. The arterioles to both types of sclerosing
glomeruli were larger in every parameter than those to
ischemic glomeruli in normotensive kidneys, for example,
lumen width (12.272.3 vs 7.671.9 mm, P¼ 0.003).
Arteriolar–glomerular relationships
In comparing arterioles with their respective glomeruli,
correlations with arteriolar diameter will be cited, those with
arteriolar luminal area being more subject to variations in
plane of section. Comparisons between the mean glomerular
capillary area and arteriolar diameter are shown in Table 5
and in Figure 2a and b. For normal glomeruli, there is no
correlation between the size of arterioles and their associated
glomerular capillaries, and the regression line is virtually flat,
as one would expect if autoregulation were maintained. By
contrast, for hypertrophic and other non-normal glomeruli,
there is an excellent positive correlation, between arteriolar
and glomerular capillary size, with fairly steeply rising
regression lines. These results are compatible with loss of
autoregulation.
Hyaline arteriolar deposits
Hyaline arteriolar lesions are earliest seen in dilated arterioles
in both normotensive and hypertensive kidneys. The size of
these lesions correlates well with arteriolar lumen area
(r¼ 0.4090, P¼ 0.0007), and also with mean glomerular
capillary size (r¼ 0.4960, P¼ 0.00002).
Sclerotic glomeruli
Sclerotic glomeruli in each biopsy were counted. They were
subdivided into two types, according to the schema of
Marcantoni et al.:15 (1) solidified, in which the sclerotic tuft
filled the entirety of the former Bowman’s space, often with
hyaline lesions recognizable, representing the sclerosis of
FSGS-type glomeruli; (2) obsolescent, in which the former
Bowman’s space was filled in by collagen surrounding the
shriveled sclerotic tuft, representing sclerosis of ischemic
glomeruli. It was found that solidified or FSGS-type sclerosis
accounted for 26.6% of sclerotic glomeruli in aging kidneys,
but 58.8% of sclerotic glomeruli in hypertensive kidneys
(w2¼ 16.80, Po0.00001). Overall, FSGS-type glomerulo-
sclerosis accounted for 12.2% of all glomeruli, and ischemic
glomerulosclerosis was found in 8.6% all glomeruli.
DISCUSSION
Clinical features
Our patients conform in their general clinical findings to
those in prior reports13,14 of patients with hypertensive
nephrosclerosis coming to biopsy. All save one of our patients
had proteinuria, and all save two were azotemic (Table 6). In
most patients the hypertension was of quite long duration
(9.476.3 years, range 0–20 years) and inadequately con-
trolled, only two of the 11 treated patients having normal
blood pressures at the time of biopsy.
Table 5 | Correlations between arteriolar lumen diameters
and mean glomerular capillary size
Normal
Hypertrophic/
FSGS/sclerosing All glomeruli
r P r P r P
Aging 0.0487 0.66 0.6417 0.000005 0.3743 0.000020
Hypertensive 0.1531 0.71 0.5022 0.000059 0.5218 0.000007
All observations 0.0710 0.50 0.5495 0.000000 0.4316 0.000000
FSGS=focal segmental glomerulosclerosis.
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Figure 2 | Comparisons of arteriolar diameter and mean glomer-
ular capillary area in aging and hypertensive kidneys. (a) As can
be seen, there is no significant correlation between the two in normal
glomeruli, consistent with maintained autoregulation. (b) By contrast,
for hypertrophic and other glomeruli, there is a strong correlation,
with a fairly steep regression line, consistent with loss of
autoregulation.
826 Kidney International (2006) 69, 823–831
o r i g i n a l a r t i c l e GS Hill et al.: Impairment of autoregulation in hypertension
Arterioles
It has been previously reported that in hypertensive
nephrosclerosis, the afferent arterioles are significantly
thickened.16 The present study demonstrates that this overall
thickening is primarily due to a shift in arteriolar types, from
predominantly normal in normotension to predominantly
hyaline arterioles in hypertension. In both normotensive and
hypertensive kidneys, as the lumen widens, the thickness and
area of the smooth muscle increase, as expected by Laplace’s
law. Further, the degree of increase of muscle in arterioles is
relatively greater in hypertensives than normotensives
(Table 3), owing to the greater pressures obtaining. However,
evidence suggests that the hypertrophic response may not be
as efficacious in hypertension, since the increase in muscle
area is much greater than the increase in lumen diameter,
whereas in normotensives these values are virtually identical
(Table 3).
Glomeruli
This study refines an earlier observation that glomeruli in
hypertension are enlarged,17 permitting this increase in size
to be divided into two components. First, there is a shift in
glomerular types from predominantly normal glomeruli
toward predominantly hypertrophic/FSGS-type glomeruli in
hypertension (Table 4), accounting for approximately 10% of
the overall increase. Second, there is an overall increase in size
of each glomerular type in hypertension, for example, for
hypertrophic glomeruli, total capillary area (22 205710 426
vs 15 34974577 mm2, P¼ 0.0038).
The reasons for this hypertrophy are multifactorial. First,
it has been demonstrated that hypertensive patients have
roughly half the number of nephrons as matched controls.18
Second, among our patients, there is further reduction of
nephrons, since they had on average 20.8% sclerotic
nephrons. Loss of autoregulation also likely plays a role in
our cases, as is discussed below.
This study has demonstrated a spectrum of glomerular
lesions in hypertension from normal through hypertrophic to
FSGS type to sclerotic, with initial increase in size followed by
decrease as the glomeruli become sclerotic. We had previ-
ously shown this pattern in normotensive aging kidneys as
well.12 This sequence now seems well established as a basic
pattern of glomerulosclerosis, both experimentally23,24,25 and
in man.25,26 The interest of the present studies is twofold:
First, they show that although the same basic sequence of
glomerular lesions is obtained in hypertensive as in normo-
tensive kidneys, in hypertension the pattern is exaggerated
with higher frequencies and larger sizes of hypertensive/
FSGS-type glomeruli (Figure 1). Second, we have shown that
the associated arterioles show the same basic pattern of initial
increase, then decrease.
Loss of autoregulation
In 1968, in a study of steroid (deoxycorticosterone acetate)-
induced hypertension, we demonstrated the association of
arteriolar dilatation with glomerular lesions,19 and suggested
at the time that these changes implied a loss of autoregula-
tion. This was subsequently confirmed by others,4 and it is
Table 6 | Patient data
Pt. no. Age Sex Race Blood pressure
Duration
hypertension
SCr
(mmol/l)
Proteinuria
(g/day) Comments
1 47 M Caucasian 155/85a 10 years 135 2.3 Ankylosing spondylitis, 10 years
2 65 M Caucasian Treatedb 9 years 290 1.0 Stones, pyelonephritis
3 57 F Caucasian 170/100 2 months known 290 ++ Both kidneys bx; opp showed massive
lymphoma
4 58 M Caucasian 130/90a 20 years 160 2.5
5 58 F Black 150/95a 6 years 180 0.5
6 72 F Caucasian 140/80a 7 years 775 5.6
7 72 M Caucasian 140/90a 10 years 170 7.7
8 31 M Caucasian 200/130 ? 119 1.73 No medical visits in 15 years
9 62 M Caucasian 140/85a 20 years 180 0
10 46 M Caucasian 120/80a 6 years 165 3.0–4.0
11 67 F Caucasian 165/95 2 years 140 2.0
12 72 M Caucasian 160/100 15 years 99 0.36
13 85 M Caucasian 240/100 10 years 500 4.35
14 50 M Caucasian 180/110 19 years 500 10
15 62 M Caucasian Treatedb 10 years 114 2.60
16 56 M Caucasian 190/100 2 years 337 5.0
17 70 M Caucasian 180/110 15 years 172 8.0
18 36 F Black 165/110a 6 months 70 1.0 Hypertension persisting postpartum
19 47 M Caucasian 180/124 18 years 160 3.8
20 44 F Caucasian 130/70a 4 years 225 1.6
21 62 M Caucasian 160/85a 12 years 370 7.04
22 55 M Black 155/90a 10 years 700 9.0
F=female; M=male; SCr=scavenger receptor.
aPatient under treatment for hypertension.
bProtocols indicated hypertension under treatment, but did not specify current values.
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now appreciated that alterations in autoregulation of renal
blood flow occur in a variety of models of renal disease, most
associated with hypertension. The most extensive studies
have been in the renal ablation (5/6 nephrectomy) mod-
el,2,20–23 but loss of autoregulation is also seen in streptozo-
tocin-induced diabetes.3 In addition, several strains of rats
show spontaneous impairment of renal autoregulation,
including fawn-hooded,24,25 Brown Norway,25 and Dahl
salt-sensitive rats.26 In all of these strains there is an increased
propensity to hyperfiltration-type glomerular lesions and
resulting renal damage. This loss of autoregulation is
manifest by dilatation of afferent arterioles8,9 and hyperper-
fusion of glomeruli24,25,27,37 from the very outset. The
glomerulosclerosis that ensues closely resembles FSGS in
man. Similarly, artificial interruption of autoregulation by
drugs such as nifedipine in rat remnant kidneys leads to
accelerated and worsened FSGS-type lesions.1,23
Loss of autoregulation is coming to be recognized in man
as well. The most clear-cut example is diabetes7,28,29 (where
in likelihood most or all of the glomeruli hyperfilter,
facilitating recognition by global measurement techniques
of glomerular filtration rate and renal blood flow). It has also
been seen in conditions leading to proteinuria,6 and it is
coming to be recognized that there may be loss of
autoregulation in the kidney of essential hypertension.5,30,31
(Here impaired autoregulation may be somewhat more
difficult to recognize because our studies suggest that only
a portion of glomeruli may be hyperfiltering at any one
time.) In blacks, although not in whites, loss of autoregula-
tion of glomerular filtration rate has been demonstrated
under basal conditions,32 with loss of autoregulation of renal
blood flow as well on a high salt diet.33 Data consistent with
loss of autoregulation has also been demonstrated in severe
hypertension, although not in moderate hypertension.30
The most striking evidence in this study for loss of
autoregulation comes from examination of the relationships
between arteriolar lumen diameter and mean glomerular
capillary area (Table 5, Figure 2). For normal glomeruli, there
is no significant correlation between the two and the
regression line is virtually flat, exactly as expected if
autoregulation were maintained. By contrast, for all other
glomeruli, there is a highly significant positive correlation
with a fairly steep regression line, consistent with loss of
autoregulation, such that glomerular capillary size mounts
steadily with increase in arteriolar diameter. Further, the
morphologic correlates of loss of autoregulation, though
still focal, are much more extensive in the hypertensive
kidney than in the normotensive kidney. In the hypertensive
kidneys, hypertrophic and FSGS-type glomeruli, the types
most safely imputed to loss of autoregulation account for
51.9% of glomeruli vs 27.4% in normotensive kidneys
(Po0.00001).
We suggest that our results should certainly apply to those
groups in whom loss of autoregulation has been demon-
strated, namely severe hypertension and blacks. However,
their applicability to groups with lesser hypertension remains
speculative. It seems likely that they would apply to a lesser
degree in those patients with microalbuminuria, with its impli-
cation of hyperfiltration, although this has not been studied
formally. Microalbuminuria is found in 30–40% of hyper-
tensive patients, and it is agreed that they have a much worse
prognosis than those without microalbuminuria.34,35 How-
ever, our results may not apply to those without micro-
albumiuria, constituting 60–70% of essential hypertensives.
Our observations permit only one definite conclusion
regarding the possible mechanism of the proposed loss of
autoregulation. The increased arteriolar lumen size to
hypertrophic/FSGS-type glomeruli is not due to simple
dilatation of arterioles that are otherwise similar to those
feeding normal glomeruli. These dilated arterioles are in fact
substantially hypertrophied in both hypertensive and normo-
tensive kidneys, although there is some evidence that the
hypertrophic response may be relatively inefficacious in
hypertension (see above).
The question may be raised as to the relative importance
of FSGS type vs ischemic glomerulosclerosis in the progres-
sion of hypertensive nephrosclerosis. The time course of
progression to sclerosis is not known, so that the best
estimate is gained by counting the numbers of sclerotic
glomeruli of the two patterns associated with sclerosis:
solidified, associated with hypertrophic/FSGS-type sclerosis,
or obsolescent, associated with ischemic glomerulosclerosis.
In our material, 57.8% sclerotic glomeruli were of the
solidified (FSGS type), compared to only 26.6% of FSGS-type
sclerotic glomeruli in aging kidneys. Another study16 found
that the solidified (FSGS-type) pattern accounted for 51.0%
of glomerulosclerosis among African Americans vs only
20.5% among Caucasians. Although the percentages
are somewhat disparate, the two series are in agreement
that FSGS-type sclerotic glomeruli, the type we would
impute to loss of autoregulation, account for at best 60%
of sclerotic glomeruli, such that loss of autoregulation
alone cannot totally explain the progression of hypertensive
nephrosclerosis.
A number of factors have been been associated with
impaired autoregulation: black race, low birth weight/
intrauterine growth retardation, aging, chronic kidney
disease, diabetes mellitus, hypercholesterolemia, hyperurice-
mia, and obesity.36 Of these, black race seems the most
prominent, with a higher incidence and graver complications
of hypertension.36,37 Tracy et al.38,39 have shown that blacks
have worse renal vascular lesions at every age than whites,
and that these lesions have their onset even before the onset
of hypertension, suggesting a functional abnormality/deficit
of the vascular smooth muscle, with loss of autoregulation in
hypertension, as outlined above. These differences parallel the
genetic differences between different strains of rats, with
some strains showing clear-cut loss of autoregulation even in
the absence of hypertension, whereas other strains do
not.33–35 Indeed, functional deficits in smooth muscle can
be invoked to explain almost all of the findings in our study.
We provide indirect evidence for such a deficit, not only in
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association of hyaline arteriolosclerosis with hypertrophic/
FSGS-type glomeruli, but also in the fact that the
hypertrophic response of arterioles in hypertension is far
greater than the increase in diameter (Table 3), suggesting
that the hypertrophic muscle may function poorly.
As a final caveat, it should be emphasized that morpho-
metric data alone cannot establish loss of autoregulation,
which is a functional determination, nor can they give an
accurate estimate of the degree of this proposed loss.
However, our data are entirely consistent with such a loss.
The changes occur focally in normotensive aging kidneys,
and much more extensively, although even there not
universally, in the biopsies of advanced hypertensive
nephrosclerosis that we have studied.
MATERIALS AND METHODS
Patient material
Twenty-two renal biopsies of hypertensive patients at the Hoˆpital
Broussais in Paris, whose biopsies were diagnosed as showing only
nephrosclerosis consistent with essential hypertension, were eval-
uated. Excluded were biopsies from patients presenting with new-
onset malignant hypertension, renal artery stenosis, diabetes,
glomerulonephritis, or any other primary renal disease. These
patients were all biopsied for proteinuria and/or renal insufficiency
(Table 6).
All arteriolar–glomerular pairs were measured in the 22 biopsies,
a total of 68 pairs (mean 3.1/biopsy). These results were then
compared with a previous study,12 in which 126 glomerular–arter-
iolar pairs from eight aging normotensive, nondiabetic patients,
aged 37–85 years, were evaluated. The specimens were derived from
non-involved portions of kidneys removed for malignancies.
Morphometry
Morphometric determinations of the different glomerular and
arteriolar parameters were made with the use of an automated
image-analyzing system, as detailed in previous communica-
tions.12,40 Measurements were performed on routine paraffin
sections stained with periodic acid-Schiff reagent only, without
counterstain, permitting definition of all extracellular matrix
components and arteriolar hyaline deposits. Glomerular parameters
reported here included: overall glomerular tuft, total capillary
surface, hilar capillary surface, number of capillaries, and total
extracellular matrix. For afferent arterioles, area, length, width, and
circumference were measured for the following: arteriole as a whole,
lumen, wall both including and excluding hyaline deposits, hyaline
deposits, and thickness of muscularis in areas with and without
deposits.
Morphologic variables
Glomeruli. These were initially divided into five types by
routine microscopy:
Normal: Glomeruli with a completely patent capillary network,
no excess of mesangium, capillary loops relatively uniform in size,
and no areas of sclerosis or adhesion to Bowman’s capsule (Figure 3a).
Hypertrophic: These glomeruli were characterized by combina-
tions of two or more of the following features: (1) evident increase
in size in comparison to most surrounding glomeruli; (2) a dilated
hilar capillary region in comparison to most surrounding glomeruli,
substantially wider than the lumen of its feeding afferent arteriole,
usually with evident dilatation of the primary branches; (3) widely
patent, often distended capillary loops, in the absence of any focal
adhesions, or sclerosis (Figure 3b); (4) marked disparity in size of
capillary loops (Figure 4).
FSGS-type lesions: These glomeruli had lesions typical of those
seen in FSGS. Early lesions, usually perihilar, showed focal capsular
adhesions, thickening of the mesangial matrix, and narrowing of
capillaries in the associated zone (Figure 3c) Hyalinosis lesions were
frequent, usually initially in a perihilar distribution. More advanced
lesions showed progressive extension of this process.
Sclerosing glomeruli: These glomeruli showed progressive increase
in extracellular matrix with shrinkage of the tuft and narrowing and
collapse of capillary loops, compared with most surrounding
glomeruli. They could be subdivided into two types: (1) Ischemic
sclerosis, with pronounced shrinkage of the glomerular tuft and
wrinkling of capillary walls (Figure 3d); (2) Advanced FSGS-type
lesions, with evidence of hyalinosis lesions and/or capsular synechiae
(Figure 3e). Totally sclerotic glomeruli with no patent capillary loops
were excluded from consideration.
Indeterminate: Glomeruli in which distinctions between normal
vs hypertrophic or normal vs ischemic categories could not readily
be made on initial examination were preliminarily categorized as
indeterminate, and recategorized after initial analysis of the other
glomerular types (see below).
Afferent arterioles. Only arterioles having patent lumens were
included in this study. They were classified into two types:
No deposits: These arterioles showed no evidence of hyaline
deposits in their walls. They were distinguished from efferent
arterioles by a thicker smooth muscle wall and generally larger
a b
c d e
Figure 3 | Glomerular types. (a) Normal glomerulus with associated
normal afferent arteriole (arrow); (b) hypertrophic glomerulus, with
hyaline deposits in entering afferent arteriole (arrow), with generally
larger capillaries than in the normal glomerulus; (c) FSGS-type
glomerulus, with prominent dilatation of primary branches and lesser
dilatation of secondary branches, and perihilar capsular adhesion and
early hyalinosis lesion; (d) sclerosing glomerulus – ischemic, with
small afferent arteriole without hyaline deposits associated (arrow),
small wrinkled capillaries, and collagen deposition beginning to fill
Bowman’s space; (e) sclerosing glomerulus – FSGS-type, shrunken
overall, with shrunken capillaries and prominent hyalinosis lesions. All
photos at same magnification. PAS without counterstain, original
magnification  400.
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lumen. In case of doubt, the arteriole and its glomerulus were
excluded from study.
Hyaline deposits: Hyaline deposits of variable size in a primarily
subendothelial position were present, rarely with deposits deeper in
the wall.
Statistics
Standard statistical methods were used, with t-tests or Mann–Whit-
ney tests to determine differences between means and standard
deviations for the various parameters, depending on the normality
of distribution of the variable. w2 testing was used to determine the
differences in distribution of variables such as arteriolar types
between groups. Pearson product–moment correlation coefficients
were used to determine the correlations between continuous
variables.
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